SPINK1 promotes colorectal cancer progression by downregulating Metallothioneins expression

Colorectal cancer (CRC) is the third most common cancer in the world, and second leading cause of cancer deaths in the US. Although, anti-EGFR therapy is commonly prescribed for CRC, patients harboring mutations in KRAS or BRAF show poor treatment response, indicating an ardent demand for new therap...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Oncogenesis
Главные авторы: Tiwari, R, Pandey, S K, Goel, S, Bhatia, V, Shukla, S, Jing, X, Dhanasekaran, S M, Ateeq, B
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2015
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4632074/
https://ncbi.nlm.nih.gov/pubmed/26258891
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/oncsis.2015.23
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы